Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8088 | 1220 | 48.5 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
120 | 23422 | GROWTH HORMONE//GROWTH HORMONE & IGF RESEARCH//INSULIN LIKE GROWTH FACTOR I |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GPE | Author keyword | 15 | 59% | 1% | 17 |
2 | RAT NEWBORN | Author keyword | 9 | 83% | 0% | 5 |
3 | TYPE II IGF RECEPTOR | Author keyword | 9 | 83% | 0% | 5 |
4 | PHARMACOL NEURODEGENERAT DISORDERS | Address | 7 | 67% | 0% | 6 |
5 | GLYCINE PROLINE GLUTAMATE | Author keyword | 6 | 100% | 0% | 4 |
6 | EXPT ENDOCRINOL INTERNAL MED | Address | 3 | 100% | 0% | 3 |
7 | NEUREN PHARMACEUT MED CHEM GRP | Address | 3 | 100% | 0% | 3 |
8 | ROENA KULYNYCH MEMORY COGNIT | Address | 3 | 35% | 1% | 7 |
9 | CENTRAL UPTAKE | Author keyword | 2 | 67% | 0% | 2 |
10 | MED PHYSIOL PAEDIAT | Address | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GPE | 15 | 59% | 1% | 17 | Search GPE | Search GPE |
2 | RAT NEWBORN | 9 | 83% | 0% | 5 | Search RAT+NEWBORN | Search RAT+NEWBORN |
3 | TYPE II IGF RECEPTOR | 9 | 83% | 0% | 5 | Search TYPE+II+IGF+RECEPTOR | Search TYPE+II+IGF+RECEPTOR |
4 | GLYCINE PROLINE GLUTAMATE | 6 | 100% | 0% | 4 | Search GLYCINE+PROLINE+GLUTAMATE | Search GLYCINE+PROLINE+GLUTAMATE |
5 | CENTRAL UPTAKE | 2 | 67% | 0% | 2 | Search CENTRAL+UPTAKE | Search CENTRAL+UPTAKE |
6 | SOMATOMEDIN | 2 | 17% | 1% | 11 | Search SOMATOMEDIN | Search SOMATOMEDIN |
7 | INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 2 | 2 | 19% | 1% | 10 | Search INSULIN+LIKE+GROWTH+FACTOR+BINDING+PROTEIN+2 | Search INSULIN+LIKE+GROWTH+FACTOR+BINDING+PROTEIN+2 |
8 | ANTI GHRH | 1 | 100% | 0% | 2 | Search ANTI+GHRH | Search ANTI+GHRH |
9 | BARNES MAZE BM | 1 | 100% | 0% | 2 | Search BARNES+MAZE+BM | Search BARNES+MAZE+BM |
10 | ENDOGENOUS NEUROPEPTIDES | 1 | 100% | 0% | 2 | Search ENDOGENOUS+NEUROPEPTIDES | Search ENDOGENOUS+NEUROPEPTIDES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GLY PRO GLU | 44 | 85% | 2% | 23 |
2 | N TERMINAL TRIPEPTIDE | 31 | 58% | 3% | 36 |
3 | GLYCINE PROLINE GLUTAMATE | 31 | 63% | 3% | 31 |
4 | VIVO ACTIONS | 26 | 87% | 1% | 13 |
5 | PSYCHOLOGICAL CAPABILITIES | 19 | 74% | 1% | 14 |
6 | CELLULAR PATTERN | 17 | 62% | 1% | 18 |
7 | NEURITE FORMATION | 11 | 29% | 3% | 32 |
8 | HYPOXIC ISCHEMIC INJURY | 7 | 17% | 3% | 38 |
9 | GPE | 7 | 67% | 0% | 6 |
10 | NEURONAL RESCUE | 5 | 32% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The many faces of insulin-like peptide signalling in the brain | 2012 | 99 | 168 | 42% |
Expanding the Mind: Insulin-Like Growth Factor I and Brain Development | 2008 | 79 | 45 | 69% |
The role of the insulin-like growth factors in the central nervous system | 1996 | 274 | 177 | 62% |
The insulin-like growth factor system and its pleiotropic functions in brain | 2005 | 208 | 460 | 38% |
Insulin and IGF receptor signalling in neural-stem-cell homeostasis | 2015 | 2 | 117 | 20% |
Circulating insulin-like growth factor I and cognitive function: Neuromodulation throughout the lifespan | 2009 | 58 | 117 | 47% |
Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain | 2006 | 122 | 192 | 45% |
Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging | 2005 | 100 | 78 | 53% |
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification? | 2014 | 16 | 280 | 14% |
Insulin and insulin-like growth factor receptors in the brain: Physiological and pathological aspects | 2014 | 8 | 47 | 23% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACOL NEURODEGENERAT DISORDERS | 7 | 67% | 0.5% | 6 |
2 | EXPT ENDOCRINOL INTERNAL MED | 3 | 100% | 0.2% | 3 |
3 | NEUREN PHARMACEUT MED CHEM GRP | 3 | 100% | 0.2% | 3 |
4 | ROENA KULYNYCH MEMORY COGNIT | 3 | 35% | 0.6% | 7 |
5 | MED PHYSIOL PAEDIAT | 2 | 67% | 0.2% | 2 |
6 | DEV MED BIOL | 2 | 13% | 1.1% | 14 |
7 | EMOT BRAIN TURING | 1 | 100% | 0.2% | 2 |
8 | ROENA KULYNYCH MEM COGNIT | 1 | 100% | 0.2% | 2 |
9 | CNS PHARMA EARLY DEV | 1 | 40% | 0.2% | 2 |
10 | INTEGRATED IMMUNOL BEHAV PROGRAM | 1 | 40% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000163686 | GRP GROWTH TORS VERTEBRATE DEV//BALANCO HIDRO SALINO NUCL MED CIRURGIA EXPT//BRAIN INSULIN RECEPTORS |
2 | 0.0000130678 | MECHANO GROWTH FACTOR//MECHANO GROWTH FACTOR MGF//IGF 1 ISOFORMS |
3 | 0.0000094538 | IGFBP 5//INSULIN LIKE GROWTH FACTOR BINDING PROTEIN//IGFBP 3 |
4 | 0.0000093781 | HYPOPITUITARISM//PITUITARY DYSFUNCTION//POST TRAUMATIC HYPOPITUITARISM |
5 | 0.0000070520 | CAPSAICIN SENSITIVE SENSORY NEURONS//BIODEF MED//REPROD ENGN |
6 | 0.0000070340 | AMES DWARF//EDISON BIOTECHNOL//AMES DWARF MICE |
7 | 0.0000058009 | INTRANASAL INSULIN//PATHOCHEM GEN NEUROCHEM//DIABETIC ENCEPHALOPATHY |
8 | 0.0000058009 | SALFORD ROYAL HOSP UNIV TRUST//MED 0613B//MED HUMAN LIFE SCI |
9 | 0.0000051443 | ACTIVITY DEPENDENT SURVIVAL//CEREBELLAR GRANULE NEURONS//CEREBELLAR GRANULE NEURON |
10 | 0.0000048955 | I CELL DISEASE//MANNOSE 6 PHOSPHATE//MUCOLIPIDOSIS TYPE III |